Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Taiwan / NCT07385976
Starting soon Observational

The Role of Blood Perfusion in Cervical Cancer, Cervical Intraepithelial Neoplasm and Ovarian Cancer Patients

NCT07385976 · tracked via the Priya Life Science Taiwan tracker
Sponsor
Far Eastern Memorial Hospital
Phase
Observational
Started
2026-01-19
Last updated
2026-02-04

Condition(s) studied

Cervical CancerCervical Intraepithelial NeoplasmOvarian Cancer

Investigational drug(s) / intervention(s)

Doppler ultrasound

Doppler ultrasound: 3D doppler ultrasound to measure VI, FI, VFI.

Study summary

This study will elucidate the role of 3D transvaginal ultrasound in assessing (1) cervical vascularity and blood flow in patients with cervical cancer and cervical intraepithelial neoplasm, and (2) tumor vascularity and blood flow in patients with ovarian cancer.

Eligibility

Sex
FEMALE
Min age
—
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Regarding the topic "Hemoperfusion characteristics of cervical cancer and precancerous lesions, and the correlation between hemoperfusion and prognosis": 1. Adult women who have had a normal cervical smear within the past three years and have no other gynecological cancers (control group). 2. Adult women with cervical cancer or precancerous lesions. * Regarding the topic "Correlation between hemoperfusion and prognosis of ovarian cancer": 1. Adult women suspected of having ovarian cancer, fallopian tube cancer, or peritoneal cancer before surgery. Exclusion Criteria: * Regarding the topic "Hemoperfusion characteristics of cervical cancer and precancerous lesions of the cervix, and the correlation between hemoperfusion and prognosis": 1\. Patients who cannot cooperate with vaginal 3D ultrasound scans. * Regarding the topic "Correlation between hemoperfusion and prognosis of ovarian cancer": 1. Patients who cannot cooperate with vaginal or abdominal 3D ultrasound scans.

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
Department of Obstetrics and Gynecology, Far Eastern Memorial Hospital, New Taipei City Banqiao
Far Eastern Memorial Hospital New Taipei City Taiwan

More Far Eastern Memorial Hospital trials in Taiwan

Exploring the Feasibility of Transcranial Ultrasound Stimulation in the Treatment of Schizophrenia Recruiting
Clinical Outcomes of Non-Indicated Staged Laparotomies in Abdominal Trauma Starting soon
Effects of Combined Upper Extremity Exercise and Pneumatic Compression Therapy on Breast Cancer-Related Lymphedema Starting soon
The AIR-CPR Study: AI-Guided Chest Compressions Recruiting
Efficacy and Safety of Super High-Flux Hemodialysis in Maintenance Dialysis Patients. SHINE-RLS (Super High-flux Dialysis Improves Neuro-symptoms and Efficacy in Restless Legs Syndrome) Starting soon

Other trials for the same condition

The Registry of Genetic Alterations of Taiwan Ovarian Cancer Recruiting
Influences of Propofol and Sevoflurane Anesthesia in Ovarian Cancer (Anesthetics) Recruiting
Exploring the Effects of Hand and Foot Exercise Intervention in Older Adults With Gynecological Cancer Receiving Chemotherapy Improvement of Peripheral Neuropathy and Quality of Life Starting soon
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22) Recruiting
A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian Cancer Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07385976 on ClinicalTrials.gov ↗ ← All trials in Taiwan